Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 3/20 | 0.52 |
| ▸ | HTR1B | P28222 | 2/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.48 |
| ▸ | DRD2 | P14416 | 1/20 | 0.47 |
| ▸ | DRD4 | P21917 | 1/20 | 0.47 |
| ▸ | DRD3 | P35462 | 1/20 | 0.47 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.47 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.47 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.47 |
| ▸ | MGLL | Q99685 | 1/20 | 0.46 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.46 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.46 |
| ▸ | HTR1D | P28221 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25819946 | 0.96 | BCHE (0.53) | BCHEHTR1BL3MBTL1TDP1MEN1 | |
| SCHEMBL13881850 | 0.94 | BCHE (0.53) | BCHEHTR1BL3MBTL1MEN1KMT2A | |
| SCHEMBL25822293 | 0.88 | HTR1B (0.57) | HTR1BL3MBTL1TDP1KDM4EDRD2 | |
| SCHEMBL25820039 | 0.87 | BCHE (0.52) | BCHEL3MBTL1TDP1DRD2DRD4 | |
| SCHEMBL13881714 | 0.87 | HTR1B (0.58) | HTR1BL3MBTL1TDP1KDM4EDRD2 | |
| SCHEMBL25819935 | 0.86 | MEN1 (0.62) | BCHEHTR1BL3MBTL1MEN1KMT2A | |
| SCHEMBL11464993 | 0.86 | BCHE (0.68) | BCHEL3MBTL1MEN1KMT2ASIGMAR1 | |
| SCHEMBL4568889 | 0.85 | TDP1 (0.55) | BCHEL3MBTL1TDP1MGLLCYP4F2 | |
| SCHEMBL19291789 | 0.85 | MEN1 (0.60) | BCHEHTR1BL3MBTL1MEN1KMT2A | |
| SCHEMBL4249052 | 0.84 | TDP1 (0.52) | BCHEL3MBTL1TDP1MGLLCYP4F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230218549-A1 | ALKOXY COMPOUNDS FOR DISEASE TREATMENT | ACUCELA INC. | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230218549-A1 | ALKOXY COMPOUNDS FOR DISEASE TREATMENT | ALDH1A2, CLN6, AGER | BCHE 1649/4885HTR1B 960/4885L3MBTL1 2438/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.